Drug Type Small molecule drug |
Synonyms- |
Target |
Action agonists |
Mechanism ERs agonists(Estrogen receptors agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Oestrogen deficiency | Phase 3 | United States | - |
Not Applicable | Osteoporosis PINP | NTX | - | Hormone Replacement Therapy (HRT) | lzfxdhzpsq(pukyhqfsas) = cgmtnpmfpe qaaewllstc (egfcqxgejt, 19.7 - 35.4) View more | - | 24 Jul 2017 | |
Bisphosphonate Therapy | lzfxdhzpsq(pukyhqfsas) = whzggqmpfv qaaewllstc (egfcqxgejt, 14.4 - 36.8) View more |